Gene therapy: prospects and problems

Bibliography

• WOOLF TM: Therapeutic repair of mutated nucleic acid sequences. Nature Biotech. (1998) 16:341–344.
   PubMed Web of Science ®Google Scholar
• BLAESE RM, CULVER KW, MILLER AD, et al.: T lymphocyte-directed gene therapy for ADA- SCID: initial trial results after 4 years. Science (1995) 270:475–480.
   PubMed Web of Science ®Google Scholar
• BORDIGNON C, NOTARANGELO LD, NOBILI N, et al.: Gene therapy in peripheral blood lymphocytes and bone marrow for ADA-immunodeficient patients. Science (1995) 270:470–475.
   PubMed Web of Science ®Google Scholar
• GROSSMAN M, RADER DJ, MULLER DW, et al.: A pilot study of ex vivo gene therapy for homozygous familial hypercholesterolaemia. Nature Med. (1995) 1:1148–1154.
   PubMed Web of Science ®Google Scholar
• KNOWLES MR, HOHNEKER KW, ZHOU Z, et al.: A controlled study of adenoviral-vector-mediated gene transfer in the nasal epithelium of patients with cystic fibrosis. New Engl. J. Med. (1995) 333:823–831.
   PubMed Web of Science ®Google Scholar
• Hitting the target with gene therapy. Gene Therapy Advisory Committee Workshop. London, UK (19 November, 1998).
   Google Scholar
• Lever AML, Goodfellow P (Eds.), British Medical Bulletin (1995) 51:12–30.
   Google Scholar
• SMITH KT, SHEPHERD AJ, BOYD JE, LEES GM: Gene delivery systems for use in gene therapy: an overview of quality assurance and safety issues. Gene Ther. (1996) 3:190–200.
   PubMed Web of Science ®Google Scholar
• KAFRI T, BLOMER U, PETERSON DA, GAGE FH, VERMA IM: Sustained expression of genes delivered directly into liver and muscle by lentiviral vectors. Nature Genet. (1997) 17:314–317.
   PubMed Web of Science ®Google Scholar
• POESCHLA EM, WONG-STAAL F, LOONEY DJ: Efficient transduction of nondividing human cells by feline immunodeficiency virus lentiviral vectors. Nature Med. (1998) 4:354–357.
   PubMed Web of Science ®Google Scholar
• •This paper describes mechanisms involved in species-restricted replication of lentivirus and shows that pseudotyped feline immunodeficiency virus (FIV) vectors can efficiently transduce dividing, growth-arrested, and postmitotic human cells.
   Google Scholar
• WILSON JM: Adenoviruses as gene-delivery vehicles. New Engl. J. Med. (1996) 334:1185–1187.
   PubMed Web of Science ®Google Scholar
• AMALFITANO A, BEGY CR, CHAMBERLAIN JS: Improved adenovirus packaging cell lines to support the growth of replication-defective gene-delivery vectors. Proc. Natl. Acad. Sci. USA (1996) 93:3352–3356.
   PubMed Web of Science ®Google Scholar
• KOCHANEK S, CLEMENS PR, MITANI K, et al.: A new adenoviral vector: Replacement of all viral coding sequences with 2 kb of DNA independently expressing both full-length dystrophin and beta-galactosidase. Proc. Natl. Acad. Sci. USA (1996) 93:5731–5736.
   PubMed Web of Science ®Google Scholar
• •Description of a new adenoviral vector characterised by large cloning capacity and lack of viral coding sequences.
   Google Scholar
• KUMAR-SINGH R, CHAMBERLAIN JS: Encapsidated adenovirus minichromosomes allow delivery and expression of a 14 kb dystrophin cDNA to muscle cells. Human Mol. Genet. (1996) 5:913–921.
   PubMed Web of Science ®Google Scholar
• •Description of a new adenoviral vector characterised by large cloning capacity and lack of viral coding sequences, similar to reference 13.
   Google Scholar
• KUMAR-SINGH R, FARBER DB: Encapsidated adenovirus mini-chromosome-mediated delivery of genes to retina: application to the rescue of photoreceptor degeneration. Human Mol. Genet. (1998) 7:1893–1900.
   PubMed Web of Science ®Google Scholar
• •A report describing delivery of cyclic GMP phosphodiesterase cDNA in vivo to mice affected with retinal degeneration. Long lasting expression (> 18 weeks) of the transgene and significant increase in thickness of outer nuclear layer was shown.
   Google Scholar
• Lever AML, Goodfellow P (Eds.), British Medical Bulletin (1995) 51:31–44.
   Google Scholar
• MUZYCZKA N: Use of adeno-associated virus as a general transduction vector for mammalian cells. Curr. Top. Microbiol. Immunol. (1992) 158:97–129.
   PubMed Web of Science ®Google Scholar
• XIAO X, LI J, SAMULSKI RJ: Production of high-titer recombinant adeno-associated virus vectors in the absence of helper adenovirus. J. Virol. (1998) 72:2224–2232.
   PubMed Web of Science ®Google Scholar
• SNYDER RO, MIA° CH, PATIJN GA, et al.: Persistent and therapeutic concentrations of human factor IX in mice after hepatic gene transfer of recombinant AAV vectors. Nature Genet. (1997) 6:270–276.
   Google Scholar
• •This report describes persistent, curative expression of Factor IX targeted to liver cells in vivo using AAV vector delivered as a single administration to mice.
   Google Scholar
• ANDERSEN JK, GARBER DA, MEANEY CA, BREAKEFIELD XO: Gene transfer into mammalian central nervous system using herpes virus vectors: extended expression of bacterial lacZ in neurons using the neuron-specific enolase promoter. Human Gene Ther. (1992) 3:487–499.
   PubMed Web of Science ®Google Scholar
• Latchman DS (Ed.), Bios Science Publishers Ltd., Oxford, UK (1994) :235–254.
   Google Scholar
• BLOMER U, NALDINI L, VERMA IM, TRONO D, GAGE FH: Applications of gene therapy to the CNS. Human Mol. Genet. (1996) 5:1397–1404.
   PubMed Web of Science ®Google Scholar
• PHELAN A, ELLIOTT G, O'HARE P: Intercellular delivery of functional p53 by the herpesvirus protein VP22. Nature Biotech. (1998) 16:440–443.
   PubMed Web of Science ®Google Scholar
• Ferre F (Ed.), Burkhauser, Cambridge, MA, USA (1997):1–23.
   Google Scholar
• MARSHALL DJ, LEIDEN JM: Recent advances in skeletal-muscle-based gene therapy. Curr. Opin. Genet. Dev. (1998) 8:360–365.
   PubMed Web of Science ®Google Scholar
• WELLS DJ: Improved gene transfer by direct plasmid injection associated with regeneration in mouse skeletal muscle. FEBS Lett. (1993) 332:179–82.
   PubMed Web of Science ®Google Scholar
• AIHARA H, MIYAZAKI J: Gene transfer by electroporation in vivo. Nature Biotech. (1998) 16:867–870.
   PubMed Web of Science ®Google Scholar
• GREGORIADIS G, SAFFIE R, DESOUZA JB: Liposome-mediated DNA vaccination. FEBS Lett. (1997) 402:107–110.
   PubMed Web of Science ®Google Scholar
• MUMPER RJ, WANG J, KLAKAMP Sc et al.: Protective interactive noncondensing (PINC) polymers for enhanced plasmid distribution and expression in rat skeletal muscle. J. Control. Rel. (1998) 52:191–203.
   PubMed Web of Science ®Google Scholar
• NOVO FJ, GORECKI DC, GOLDSPINK D, MACDERMOT KD: Gene transfer and expression of human alpha-galactosidase from mouse muscle in vitro and in vivo. Gene Ther. (1997) 4:488–492.
   PubMed Web of Science ®Google Scholar
• Wolff JA (Ed.), Birkhauser, Boston, USA (1994):193–209.
   Google Scholar
• ZHU N, LIGGITT D, LIU Y, DEBS R: Systemic gene expression after intravenous DNA delivery into adult mice. Science (1993) 261:209–211.
   PubMed Web of Science ®Google Scholar
• HONG K, ZHENG W, BAKER A, PAPAHADJOPOULOS D: Stabilization of cationic liposome-plasmid DNA complexes by polyamines and poly(ethylene glycol)-phospholipid conjugates for efficient in vivo gene delivery. FEBS Lett. (1997) 400:233–237.
   PubMed Web of Science ®Google Scholar
• HART SL, ARANCIBIA-CARCAMO CV, WOLFERT MA, et al.: Lipid-mediated enhancement of transfection by a nonviral integrin-targeting vector. Human Gene Ther. (1998) 9:575–585.
   PubMed Web of Science ®Google Scholar
• HUI KM, ANG PT, HUANG L, TAY SK: Phase I study of immunotherapy of cutaneous metastases of human carcinoma using allogeneic and xenogeneic MHC DNA-liposome complexes. Gene Ther. (1997) 4:783–790.
   PubMed Web of Science ®Google Scholar
• LAI LW, CHAN DM, ERICKSON RP, HSU SJ, LIEN YH: Correction of renal tubular acidosis in carbonic anhydrase II-deficient mice with gene therapy. J. Clin. Invest. (1998) 101:1320–1325.
   PubMed Web of Science ®Google Scholar
• ZOU Y, ZONG G, LING YH, et al.: Effective treatment of early endobron- chial cancer withregional administration of liposome-p53 complexes. J. Natl. Cancer Inst. (1998) 90:1130–1137.
   PubMed Web of Science ®Google Scholar
• MATSUI H, JOHNSON LG, RANDELL SH, BOUCHER RC: Loss of binding and entry of liposome-DNA complexes decreases transfection efficiency in differentiated airway epithelial cells. J. Biol. Chem. (1997) 272:1117–1126.
   PubMed Web of Science ®Google Scholar
• YONEMITSU Y, KANEDA Y, MURAISHI A, et al.: HVJ (Sendai virus)-cationic liposomes: a novel and potentially effective liposome-mediated technique for gene transfer to the airway epithelium. Gene Ther. (1997) 4:631–638.
   PubMed Web of Science ®Google Scholar
• RIVIERA VM, CLACKSON T, NATESAN S, et al.: A humanised system for pharmacological control of gene expression. Nature Med. (1996) 2:1028–1032.
   PubMed Web of Science ®Google Scholar
• LIANG X, HARTIKA J, SUKHU L, MANTHORPE M, HOBART P: Novel high expressing and antibiotic controlled plasmid vectors designed for use in gene therapy. Gene Ther. (1996) 3:530–536.
   Google Scholar
• RINSCH C, REGULIER E, DEGLON Net al.: A gene therapy approach to regulated delivery of erythropoietin as a function of oxygen tension. Human Gene Ther. (1997) 8:1881–1889.
   PubMed Web of Science ®Google Scholar
• ••An example of physiological regulation of transgene expression in vivo using anhypoxia-inducible promoter.
   Google Scholar
• SCHIEDNER G, MORRAL N, PARKS RJ, et al.: Genomic DNA transfer with a high capacity adenovirus vector results in improved in vivo gene expression and decreased toxicity. Nature Genet. (1998) 18:180–183.
   PubMed Web of Science ®Google Scholar
• ••Intravenous injection of gutless adenoviral vector containing the complete humanalpha-l-antitrypsin locus resulted in tissue-specific transcriptional regulation, high levels of very stable expression (more than ten months) and decreased acute and chronic toxicity in mice. These results indicate advantages of regulated gene expression using genomic DNA for gene transfer and the possibility of targeting large DNA fragments in vivo.
   Google Scholar
• IKENO M, GRIMES B, OKAZAKI T, et al.: Construction of YAC-based mammalian artificial chromosomes. Nature Biotech. (1998) 16:431–439.
   PubMed Web of Science ®Google Scholar
• KELLEHER ZT, FU H, LIVANOS E, et al.: Mouse artificial episomal chromosomes for shuttling 100 kb of self-replicating circular human DNA in mouse cells. Nature Biotech. (1998) 16:762–768.
   PubMed Web of Science ®Google Scholar
• WIERTZ EJ, MUKHERJEE S, PLOEGH HL: Viruses use stealth technology to escape from the host immune system. Mol. Med. Today (1997) 3:116–123.
   PubMedGoogle Scholar
• KAFRI T, MORGAN D, KRAHL T, et al.: Cellular immune response to adenoviral vector infected cells does not require de novo viral gene expression: Implications for gene therapy. Proc. Natl. Acad. Sci. USA (1998) 95:11377–11382.
   PubMed Web of Science ®Google Scholar
• •Cells transduced with adenovirus unable to make viral proteins were recognised and destroyed by the immune system.
   Google Scholar
• SATO Y, ROMAN M, TIGHE H, et al.: Immunostimulatory DNA sequences necessary for effective intradermal gene immunization. Science (1996) 273:352–354.
   PubMed Web of Science ®Google Scholar
• ••Paper describing characterisation of short immunostimulatory sequences in a number ofgenes present in commonly used plasmids.
   Google Scholar
• MCMAHON JM, WELLS KE, BAMFO JE, CARTWRIGHT MA, WELLS DJ: Inflammatory responses following direct injection of plasmid DNA into skeletal muscle. Gene Ther. (1998) 5:1283–1290.
   PubMed Web of Science ®Google Scholar
• TRIP ATHY SK, BLACK HB, GOLDWASSER E, LEIDEN JM: Immune responses to transgene-encoded proteins limit the stability of gene expression after injection of replication-defective adenovirus vectors. Nature Med. (1996) 2:545.
   PubMed Web of Science ®Google Scholar
• OHTSUKA Y, UDAKA K, YAMASHIRO Y, YAGITA H, OKUMURA K: Dystrophin acts as a transplantation rejection antigen in dystrophin-deficient mice: implication for gene therapy. J. Immunol. (1998) 160:4635–4640.
   PubMed Web of Science ®Google Scholar
• BITTNER RE, SHORNY S, STREUBEL B, et al.: Serum antibodies to the deleted dystrophin sequence after cardiac transplantation in a patient with Becker's muscular dystrophy. New Engl. J. Med. (1995) 333:732–733.
   PubMedGoogle Scholar
• KOPROWSKI H, WEINER DB: DNA vaccination/genetic vaccination. Curr. Topics Microbiol. Immunol. (1998) 226:5–13.
   Google Scholar
• HUYGEN K, CONTENT J, DENIS 0 et al.: Immunogenicity and protective efficacy of a tuberculosis DNA vaccine. Nature Med. (1996) 2:893–898.
   PubMed Web of Science ®Google Scholar
• TASCON RE, COLSTON MJ, RAGNO S, et al.: Vaccination against tuberculosis by DNA injection. Nature Med. (1996) 2:888–892.
   PubMed Web of Science ®Google Scholar
• CALAROTA S, BRATT G, NORDLUND S, et al.: Cellular cytotoxic response induced by DNA vaccination in HIV-1-infected patients. Lancet (1998) 351:1320–1325.
   PubMed Web of Science ®Google Scholar
• HURFORD RK, DRANOFF G, MULLIGAN RC, TEPPER RI: Gene therapy of metastatic cancer by in vivo retroviral gene targeting. Nature Genet. (1995) 10:430–435.
   PubMed Web of Science ®Google Scholar
• SYRENGELAS AD, CHEN T, LEVY R: DNA immunization induces protective immunity against B-cell lymphoma. Nature Med. (1996) 2:1038–1041.
   PubMed Web of Science ®Google Scholar
• WAISMAN A, RUIZ PJ, HIRSCHBERG DL, et al.: Suppressive vaccination with DNA encoding a variable region gene of the T-cell receptor prevents autoimmune encephalomyelitis and activates Th2 immunity. Nature Med. (1996) 2:899–905.
   PubMed Web of Science ®Google Scholar
• ROTH JA, NGUEN D, LAWRENCE D, et al.: Retrovirus - mediated wild type p53 gene transfer to tumours of patients with lung cancer. Nature Med. (1996) 2:985–991.
   PubMed Web of Science ®Google Scholar